Association of estrogen replacement therapy with the risk of osteoarthritis of the hip in elderly white women. Study of Osteoporotic Fractures Research Group.

Michael C. Nevitt, Jane A. Cauley(University of Pittsburgh), Marc C. Hochberg(University of Maryland, Baltimore), Harry K. Genant(University of California, San Francisco), Steven R. Cummings(University of California, Los Angeles), Nancy E. Lane(University of California Davis Medical Center), Jean C. Scott(University of Maryland, Baltimore), Alice Pressman(Sutter Health)
PubMed
October 14, 1996
Cited by 195

Related Papers

Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
|New England Journal of Medicine|2009|3.4k
RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2 FOR TREATMENT OF OPEN TIBIAL FRACTURES
|Journal of Bone and Joint Surgery|2002|1.3k
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women
|Osteoporosis International|2007|1.2k
Effects of Estrogen Plus Progestin on Risk of Fracture and Bone Mineral Density<SUBTITLE>The Women's Health Initiative Randomized Trial</SUBTITLE>
|JAMA|2003|1.2k
Association of Long-Distance Corridor Walk Performance With Mortality, Cardiovascular Disease, Mobility Limitation, and Disability
|JAMA|2006|943